Tenaya Therapeutics, Inc. Common Stock

€0.6315
EUR
Last updated on --.
24h volume4.43M
24h highest0.68509 EUR
24h lowest0.61658 EUR
24h Price movement+0.01%

TNYA recent prices

24 Hours
+0.01%+€0.0₄8672
30 days
-27.18%-€0.2357
60 days
-1.59%-€0.010233
90 days
-18.64%-€0.14465

Key data

Previous close0.63141 EUR
Market cap137.01M EUR
Volume4.43M
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.32954 EUR
Net income (FY)-71.98M EUR
Revenue (FY)195.12K EUR
Last report dateMay 6, 2026

About Tenaya Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
HeadquartersSOUTH SAN FRANCISCO
Employees (FY)70.00
Revenue per employee (FY)2.79K EUR
Net income per employee (FY)-1.03M EUR
Listed onNasdaq
Official website

TNYA conversion tables

TNYATNYA
EUREUR
0.5 TNYA0.31575 EUR
1 TNYA0.6315 EUR
5 TNYA3.157 EUR
10 TNYA6.314 EUR
EUREUR
TNYATNYA
0.5 EUR0.79177 TNYA
1 EUR1.583 TNYA
5 EUR7.917 TNYA
10 EUR15.83 TNYA

FAQ

TNYA is trading at €0.6315, +0.01% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TNYA stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TNYA is currently trading at €0.6315, +0.01% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TNYA price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TNYA's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TNYA; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TNYA's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Tenaya Therapeutics, Inc. Common Stock's market cap is currently 137.01M EUR. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume4.43M
24h highest0.68509 EUR
24h lowest0.61658 EUR
24h Price movement+0.01%
TNYATNYA
EUREUR
Start trade with TNYA Perpetual